Nifty
Sensex
:
:
23250.10
76295.36
-82.25 (-0.35%)
-322.08 (-0.42%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 543427 | NSE: MEDPLUS

811.70
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  794.60
  •  823.50
  •  779.00
  •  790.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  277238
  •  2234.01
  •  875.65
  •  616.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,776.55
  • 67.90
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,508.95
  • N/A
  • 5.33

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 40.39%
  • 3.75%
  • 13.21%
  • FII
  • DII
  • Others
  • 15.23%
  • 23.98%
  • 3.44%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 14.40
  • 14.17

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 22.67
  • 5.15

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 105.42
  • -11.92

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 140.87

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 5.75

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 26.12

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
5.48
11.12
16.36
22.88
P/E Ratio
135.89
66.98
45.52
32.54
Revenue
5625
6366
7421
8631
EBITDA
354
490
607
750
Net Income
65
135
201
281
ROA
2.3
4.3
5.8
7.4
P/B Ratio
5.64
5.2
4.68
4.12
ROE
4.27
7.77
10.87
13.52
FCFF
72.88
308.84
262.52
310.04
FCFF Yield
0.74
3.14
2.67
3.15

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
1,561.45
1,441.47
8.32%
1,576.17
1,408.59
11.90%
1,488.83
1,284.30
15.93%
1,490.50
1,252.98
18.96%
Expenses
1,428.92
1,349.69
5.87%
1,451.73
1,323.50
9.69%
1,395.06
1,212.95
15.01%
1,384.63
1,171.35
18.21%
EBITDA
132.52
91.78
44.39%
124.44
85.09
46.25%
93.76
71.34
31.43%
105.87
81.63
29.69%
EBIDTM
8.49%
6.37%
7.89%
6.04%
6.30%
5.56%
7.10%
6.51%
Other Income
12.52
9.79
27.89%
11.60
10.37
11.86%
8.71
9.39
-7.24%
10.46
13.69
-23.59%
Interest
25.97
24.50
6.00%
25.12
23.54
6.71%
24.66
23.27
5.97%
25.13
22.27
12.84%
Depreciation
62.47
57.11
9.39%
63.14
55.47
13.83%
60.03
52.41
14.54%
59.21
55.80
6.11%
PBT
56.60
19.96
183.57%
47.78
16.44
190.63%
17.79
5.05
252.28%
31.99
17.25
85.45%
Tax
10.73
6.26
71.41%
9.08
1.90
377.89%
3.44
1.29
166.67%
-1.58
-9.30
-
PAT
45.87
13.71
234.57%
38.70
14.54
166.16%
14.34
3.76
281.38%
33.56
26.56
26.36%
PATM
2.94%
0.95%
2.46%
1.03%
0.96%
0.29%
2.25%
2.12%
EPS
3.83
1.15
233.04%
3.24
1.22
165.57%
1.20
0.32
275.00%
2.79
2.23
25.11%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Net Sales
6,116.95
5,624.85
4,557.58
3,779.28
3,069.27
2,870.60
Net Sales Growth
13.54%
23.42%
20.59%
23.13%
6.92%
 
Cost Of Goods Sold
4,685.93
4,391.63
3,557.69
2,982.37
2,425.24
2,336.54
Gross Profit
1,431.02
1,233.23
999.89
796.90
644.03
534.07
GP Margin
23.39%
21.92%
21.94%
21.09%
20.98%
18.60%
Total Expenditure
5,660.34
5,253.56
4,276.21
3,490.40
2,840.05
2,736.93
Power & Fuel Cost
-
45.50
31.71
17.78
13.29
13.70
% Of Sales
-
0.81%
0.70%
0.47%
0.43%
0.48%
Employee Cost
-
625.52
545.13
393.92
338.65
272.40
% Of Sales
-
11.12%
11.96%
10.42%
11.03%
9.49%
Manufacturing Exp.
-
9.11
6.19
4.57
6.18
8.28
% Of Sales
-
0.16%
0.14%
0.12%
0.20%
0.29%
General & Admin Exp.
-
76.56
62.06
39.66
24.88
21.00
% Of Sales
-
1.36%
1.36%
1.05%
0.81%
0.73%
Selling & Distn. Exp.
-
98.28
67.76
47.35
29.27
47.58
% Of Sales
-
1.75%
1.49%
1.25%
0.95%
1.66%
Miscellaneous Exp.
-
6.96
5.67
4.75
2.54
37.43
% Of Sales
-
0.12%
0.12%
0.13%
0.08%
1.30%
EBITDA
456.59
371.29
281.37
288.88
229.22
133.67
EBITDA Margin
7.46%
6.60%
6.17%
7.64%
7.47%
4.66%
Other Income
43.29
40.01
46.08
31.36
21.55
17.28
Interest
100.88
113.65
98.72
82.94
67.40
46.80
Depreciation
244.85
224.21
181.56
119.36
88.27
74.81
PBT
154.16
73.44
47.16
117.94
95.10
29.36
Tax
21.67
7.87
-2.94
23.23
31.99
27.57
Tax Rate
14.06%
10.72%
-6.23%
19.70%
33.64%
93.90%
PAT
132.47
65.48
49.76
95.81
63.86
1.79
PAT before Minority Interest
132.39
65.58
50.10
94.72
63.11
1.79
Minority Interest
-0.08
-0.10
-0.34
1.09
0.75
0.00
PAT Margin
2.17%
1.16%
1.09%
2.54%
2.08%
0.06%
PAT Growth
126.17%
31.59%
-48.06%
50.03%
3,467.60%
 
EPS
11.09
5.48
4.16
8.02
5.34
0.15

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
1,577.93
1,491.18
1,417.77
730.55
527.80
Share Capital
23.91
23.86
23.86
0.45
0.19
Total Reserves
1,523.66
1,436.88
1,382.52
681.45
291.47
Non-Current Liabilities
839.74
797.40
647.39
381.01
298.35
Secured Loans
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
55.71
61.33
94.94
18.35
17.74
Current Liabilities
525.93
476.58
559.01
444.84
481.09
Trade Payables
253.03
260.14
246.23
148.09
234.15
Other Current Liabilities
241.81
189.35
148.29
111.39
122.35
Short Term Borrowings
0.00
0.00
142.68
135.24
105.05
Short Term Provisions
31.09
27.09
21.80
50.12
19.54
Total Liabilities
2,943.03
2,764.48
2,623.65
1,556.95
1,308.54
Net Block
1,241.83
1,137.96
798.73
517.30
419.46
Gross Block
1,861.94
1,615.62
1,114.11
739.16
689.67
Accumulated Depreciation
620.11
477.66
315.38
221.86
270.21
Non Current Assets
1,375.48
1,283.77
991.95
603.97
492.76
Capital Work in Progress
11.08
25.47
20.45
5.54
4.94
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
116.72
120.19
172.75
81.08
68.33
Other Non Current Assets
5.85
0.15
0.02
0.05
0.04
Current Assets
1,567.55
1,480.72
1,631.71
952.98
815.78
Current Investments
0.00
0.03
0.03
0.03
0.25
Inventories
1,340.23
1,144.09
914.98
749.96
643.55
Sundry Debtors
17.50
8.65
6.04
5.37
6.40
Cash & Bank
141.68
283.83
34.41
118.59
140.69
Other Current Assets
68.13
9.91
31.74
7.69
24.87
Short Term Loans & Adv.
53.84
34.20
644.51
71.34
18.16
Net Current Assets
1,041.62
1,004.14
1,072.70
508.14
334.69
Total Assets
2,943.03
2,764.49
2,623.66
1,556.95
1,308.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
143.74
90.41
169.89
2.89
-6.59
PBT
73.44
47.16
117.94
95.10
29.36
Adjustment
330.62
272.76
187.88
182.28
155.41
Changes in Working Capital
-231.10
-215.58
-102.37
-245.77
-176.50
Cash after chg. in Working capital
172.96
104.34
203.45
31.61
8.27
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-29.22
-13.94
-33.56
-28.71
-14.86
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-82.80
429.44
-703.13
-34.55
-27.55
Net Fixed Assets
-17.99
-111.19
-80.06
-17.76
Net Investments
-12.56
-498.71
-9.95
-27.41
Others
-52.25
1,039.34
-613.12
10.62
Cash from Financing Activity
-198.10
-170.25
440.43
-5.63
89.83
Net Cash Inflow / Outflow
-137.17
349.60
-92.81
-37.28
55.69
Opening Cash & Equivalents
228.38
-121.23
-28.42
8.87
-46.82
Closing Cash & Equivalent
91.21
228.38
-121.23
-28.42
8.87

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
129.47
122.44
117.89
3044.19
15034.43
ROA
2.30%
1.86%
4.51%
4.40%
0.18%
ROE
4.36%
3.50%
9.07%
12.96%
0.59%
ROCE
12.19%
9.56%
16.56%
21.69%
14.34%
Fixed Asset Turnover
3.28
3.39
4.13
4.38
6.75
Receivable days
0.84
0.58
0.54
0.69
0.96
Inventory Days
79.52
81.27
79.28
81.18
65.97
Payable days
21.33
25.98
24.13
28.76
24.12
Cash Conversion Cycle
59.03
55.87
55.69
53.10
42.81
Total Debt/Equity
0.00
0.00
0.10
0.20
0.36
Interest Cover
1.65
1.48
2.42
2.41
1.63

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.